Latest news
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal - Pharmacy TimesPharmacy Times · Fri, 07 Aug 2026 16:09:33 GMTAfter 2 CRLs, FDA Approves Vusolimogene Oderparepvec With Nivolumab for Advanced Melanoma - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 20:58:22 GMTFDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 16:43:18 GMTBeyond the Approval: Operationalizing Zongertinib for HER2-Mutant Lung Cancer - Pharmacy TimesPharmacy Times · Wed, 05 Aug 2026 15:22:02 GMTFive Solid Tumor Advances That Defined July 2026 - Pharmacy TimesPharmacy Times · Fri, 31 Jul 2026 15:58:27 GMTA Pharmacist’s Guide to Modern Menopause Management in 2026 - Pharmacy TimesPharmacy Times · Thu, 30 Jul 2026 19:48:18 GMT